Ro’s Post

Physicians Reveals GLP-1s for Weight Loss are Overprescribed - HIT Consultant Physicians Warn of Overprescription of GLP-1s for Weight Loss #GLP1Overprescription A group of physicians has raised concerns about the overprescription of GLP-1s for weight loss, citing potential risks and lack of evidence for long-term efficacy #PhysicianConcerns GLP-1s are commonly used to treat type 2 diabetes but have been increasingly prescribed off-label for weight loss #OffLabelUse Physicians urge caution and more research to determine the appropriate use of GLP-1s for weight loss #ResearchNeeded The potential benefits and risks of GLP-1s for weight loss should be carefully weighed by healthcare providers before prescribing #RiskAssessment Healthcare IT professionals should ai.mediformatica.com #health #glp1 #about #virta #physicians #survey #weightlo #medical #providers #research #virtahealth #community #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3LSyMJ0)

With over 100M people living with obesity in America and a shortage of providers, technology is key to scaling high-quality care to support patients. Obesity is a condition that requires high-touch, ongoing care. I share how technology can enable us to deliver access to this care at scale, assure quality and safety, and support continuity of care in MedCity News. Read more here: https://lnkd.in/e_28uvS4

In the fourth of a six-part Healio series, learn how our co-founder Katherine Saunders, MD, approaches collaboration among multiple practitioners, especially primary care providers.

Multimorbidity is becoming increasingly common, posing significant challenges for healthcare delivery. This insightful review addresses the current barriers and proposes an innovative model for managing cardiovascular-kidney-metabolic (CKM) syndrome. 🩺 👉Discover how a CKM service can revolutionize care by improving clinical outcomes, enhancing quality of life, and optimizing the use of protective medications. 🔗 Read the full article here - https://lnkd.in/d3FfRqY8 #CaReMeO2024 #diabetes #cardiovasculardisease #renaldisease #primarycarephysicians

"The Missing Piece campaign came together as more medical experts found patient results were regularly stymied by a lack of access to medical pathology technology, which allows precise diagnosis, treatment and prevention across several conditions." James Dowling, The Australian. “The health system isn’t designed for chronic diseases like diabetes. We are moving and things are improving with this, but the whole system was based around acute care right from the beginning.” Ray Kelly, Too Deadly for Diabetes. “All the reviews that are going on at the moment come to the same conclusion, that we need to invest earlier in the patient journey. We need to prevent the issues that are occurring before they occur, and we need to manage these people better.” A/Prof Colman Taylor, Chief Vision Officer, HTAnalysts   Read the full article in The Australian: https://lnkd.in/gmwsTuKc Visit the campaign website: https://lnkd.in/gZmUdSVz Watch the video: https://lnkd.in/ggy3Sz-M and join us in raising the volume of this important campaign. In healthcare, every piece is crucial. Pathology technology silently guides diagnosis, treatment, and prevention, ensuring seamless healthcare. Together, let's ensure equitable access to cutting-edge medical technologies for all Australians. #MissingPiece #diagnostics #pathologytechnology #healthcareinnovation Humanise Health Krystal Barter Madeline O'Donoghue

Our migraine preferences study demonstrated a high degree of heterogeneity in preference for route of administration (oral, IV, subcutaneous). The findings have implication to understanding adherence and containing healthcare costs. Enjoy! https://lnkd.in/gj_KCkR6

The #Automatic #Pill #Dispenser Market: Driving Healthcare Efficiency and Safety from 2024 to 2030 𝐆𝐞𝐭 𝐚 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬..!!https://lnkd.in/gt9ucbKP 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬: The surge in the global elderly population and the #prevalence of chronic diseases such as diabetes and cancer are major drivers for the Automatic Pill Dispenser Market. #According to the World Health Organization (WHO), the global elderly population is projected to #increase from 728 million in 2020 to 1.5 billion by 2040. This #demographic shift, coupled with an increase in memory-related conditions, underscores the need for automated medication management solutions. 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐢𝐧𝐠 𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 Automatic pill dispensers have become #indispensable in healthcare settings, especially in inpatient care units. These devices not only provide secure #medication storage but also offer computerized tracking of narcotic and other restricted drug usage. This #reduces manual effort for healthcare professionals, such as end-of-shift narcotic counts, allowing them to focus more on direct #patient care. Advanced features like barcode scanning and Bluetooth connectivity further enhance medication accuracy, preventing errors and ensuring patient safety. 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐋𝐞𝐚𝐝𝐬 𝐭𝐡𝐞 𝐖𝐚𝐲 North America dominated the Automatic Pill #Dispenser Market with a 79% share in 2023 and is #projected to continue its growth trajectory, reaching $1.62 billion by 2030. The region's growth is #primarily driven by the increasing elderly #population and the rising prevalence of chronic diseases. Europe follows as the second-largest #market, fueled by the growing prevalence of diabetes, cardiovascular disorders, and obesity. Automatic Pill Dispenser Market Key Players McKesson Yuyama Co., Ltd Talyst ScriptPro Baxter International Inc. #SmartPharmacy #MedicationAdherence #PharmacySolutions #ChronicDiseaseManagement #GeriatricCare

Culturally competent and inclusive endometriosis care https://lnkd.in/ees7iXDe

Yes, yes and YES. A big yes. We are seeing so much change around the horizon. Independence is so underrated. Autonomy is so needed. Yes, that’s what @somedocs fights for. Autonomy. Of relevance, we are running an obesity medicine conference in September, and are now seating speakers. We have two co-chairs, Franchell Hamilton, MD, FASMBS, FACS and Sue Benson-Davies, PhD, DCN, MPH. https://lnkd.in/eijCcPZx #obesity #obesitymedicine #autonomy #healthcare #doctors #somedocs

Non-adherence to medication poses a significant challenge in managing cardiovascular diseases, often influencing the progression and outcomes of these conditions. Therefore, strategies aimed at enhancing medication adherence play a crucial role in improving patient health. In a recent study, the introduction of innovative technology in the form of smartphone app reminders proved effective in enhancing adherence to essential medications among patients. By leveraging mobile health technology, patients were empowered to better adhere to their prescribed drug regimens, leading to improved management of their cardiovascular conditions. This implementation underscores the scalability of mobile health solutions, offering a promising avenue for addressing medication adherence challenges on a broader scale and unlocking countless possibilities for improving patient outcomes in cardiovascular care. The incorporation of the MMAS served as a valuable resource for assessing medication adherence. The Morisky scale provided a standardized and validated method for evaluating patients' adherence behaviors, allowing researchers to quantitatively measure adherence levels with precision. Paired with an objective measure like a smartphone app, which offers real-time reminders and tracking, the MMAS enhanced the study's effectiveness in assessing and improving medication adherence.